nplate privacy optin

The trial was terminated early due to no statistical significance observed between durvalumab and cetuximab for patients with head and neck squamous cell carcinoma.

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Leading multidisciplinary oncology professionals look back at how the COVID-19 pandemic changed cancer care.

Retrospective data may offer actionable guidance for clinicians treating patients with non–small cell lung cancer and brain metastases.